Evidence map›Paper›PMID 39261247›Full record

ArticleCytokine2024

Corrigendum to "Poly I:C vaccination drives transient CXCL9 expression near B cell follicles in the lymph node through type-I and type-II interferon signaling" [Cytokine 183 (2024) 156731].

Alexander G Ball, Katerina Morgaenko, Parastoo Anbaei, Sarah E Ewald, Rebecca R Pompano

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cytokine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Alexander G BallDepartment of Microbiology Cancer Biology and Immunology, University of Virginia, Charlottesville, VA 22903, USA; Carter Immunology Center and UVA Cancer Center, University of Virginia, Charlottesville, VA 22903, USA.
Katerina MorgaenkoDepartment of Biomedical Engineering, University of Virginia School of Engineering and Applied Sciences, Charlottesville, VA 22904, USA.
Parastoo AnbaeiDepartment of Chemistry, University of Virginia College of Arts and Sciences, Charlottesville, VA 22904, USA.
Sarah E EwaldDepartment of Microbiology Cancer Biology and Immunology, University of Virginia, Charlottesville, VA 22903, USA; Carter Immunology Center and UVA Cancer Center, University of Virginia, Charlottesville, VA 22903, USA.
Rebecca R PompanoDepartment of Biomedical Engineering, University of Virginia School of Engineering and Applied Sciences, Charlottesville, VA 22904, USA; Department of Chemistry, University of Virginia College of Arts and Sciences, Charlottesville, VA 22904, USA; Carter Immunology Center and UVA Cancer Center, University of Virginia, Charlottesville, VA 22903, USA. Electronic address: rrp2z@virginia.edu.

Funding

Multi-organ culture and pumping systems for ex vivo models of immunity in hybrid tissue-chipsR01AI174207 · NIAID · UNIVERSITY OF VIRGINIA · PI Rebecca R Pompano · 2023 to 2026
$2.4M
Modeling immunity with a hybrid lymph node tissue-chipR01AI131723 · NIAID · UNIVERSITY OF VIRGINIA · PI POMPANO, REBECCA R · 2018 to 2022
$2.3M
NIAID NIH HHS R01 AI131723NIAID NIH HHS R01 AI174207
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39261247
PMCPMC11696711

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.